236 related articles for article (PubMed ID: 32448024)
1. Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation.
Chen N; Alam AB; Lutsey PL; MacLehose RF; Claxton JS; Chen LY; Chamberlain AM; Alonso A
J Am Heart Assoc; 2020 Jun; 9(11):e015089. PubMed ID: 32448024
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database.
Subramanya V; Claxton JS; Lutsey PL; MacLehose RF; Chen LY; Chamberlain AM; Norby FL; Alonso A
BMC Cardiovasc Disord; 2021 Dec; 21(1):598. PubMed ID: 34915858
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
Vora AN; Dai D; Matsuoka R; Harrison JK; Hughes GC; Sherwood MW; Piccini JP; Bhardwaj B; Lopes RD; Cohen D; Holmes DR; Thourani VH; Peterson E; Kirtane A; Kapadia S; Vemulapalli S
JACC Cardiovasc Interv; 2018 Sep; 11(17):1746-1756. PubMed ID: 30190063
[TBL] [Abstract][Full Text] [Related]
4. Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.
Martinez BK; Baker WL; Sood NA; Bunz TJ; Meinecke AK; Eriksson D; Coleman CI
Pharmacotherapy; 2019 Feb; 39(2):196-203. PubMed ID: 30597611
[TBL] [Abstract][Full Text] [Related]
5. Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation.
Claxton JS; Chamberlain AM; Lutsey PL; Chen LY; MacLehose RF; Bengtson LGS; Alonso A
Am J Med; 2020 Oct; 133(10):e554-e567. PubMed ID: 32320695
[TBL] [Abstract][Full Text] [Related]
6. Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation.
Yong CM; Tremmel JA; Lansberg MG; Fan J; Askari M; Turakhia MP
J Am Heart Assoc; 2020 May; 9(10):e015689. PubMed ID: 32394763
[TBL] [Abstract][Full Text] [Related]
7. Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.
O'Neal WT; Sandesara PB; Claxton JS; MacLehose RF; Chen LY; Bengtson LGS; Chamberlain AM; Norby FL; Lutsey PL; Alonso A
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29525778
[TBL] [Abstract][Full Text] [Related]
8. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
9. Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation.
Lutsey PL; Norby FL; Ensrud KE; MacLehose RF; Diem SJ; Chen LY; Alonso A
JAMA Intern Med; 2020 Feb; 180(2):245-253. PubMed ID: 31764956
[TBL] [Abstract][Full Text] [Related]
10. Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people.
Hanon O; Assayag P; Belmin J; Collet JP; Emeriau JP; Fauchier L; Forette F; Friocourt P; Gentric A; Leclercq C; Komajda M; Le Heuzey JY; ;
Arch Cardiovasc Dis; 2013 May; 106(5):303-23. PubMed ID: 23769405
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial).
Millenaar D; Schumacher H; Brueckmann M; Eikelboom JW; Ezekowitz M; Slawik J; Ewen S; Ukena C; Wallentin L; Connolly S; Yusuf S; Böhm M
Am J Cardiol; 2021 Jun; 149():27-35. PubMed ID: 33757788
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis.
Gallagher C; Nyfort-Hansen K; Rowett D; Wong CX; Middeldorp ME; Mahajan R; Lau DH; Sanders P; Hendriks JM
Open Heart; 2020; 7(1):e001257. PubMed ID: 32509316
[TBL] [Abstract][Full Text] [Related]
13. Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.
O'Neal WT; Claxton JS; Sandesara PB; MacLehose RF; Chen LY; Bengtson LGS; Chamberlain AM; Norby FL; Lutsey PL; Alonso A
J Am Coll Cardiol; 2018 Oct; 72(16):1913-1922. PubMed ID: 30309468
[TBL] [Abstract][Full Text] [Related]
14. Age-Dependent Anticoagulant Therapy for Atrial Fibrillation Patients with Intermediate Risk of Ischemic Stroke: A Nationwide Population-Based Study.
Choi SY; Kim MH; Lee KM; Cho YR; Park JS; Yun SC; Lip GYH
Thromb Haemost; 2021 Sep; 121(9):1151-1160. PubMed ID: 33307565
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Martínez-Montesinos L; Rivera-Caravaca JM; Agewall S; Soler E; Lip GYH; Marín F; Roldán V
Biomed Pharmacother; 2023 Feb; 158():114064. PubMed ID: 36495662
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
Durheim MT; Holmes DN; Blanco RG; Allen LA; Chan PS; Freeman JV; Fonarow GC; Go AS; Hylek EM; Mahaffey KW; Pokorney SD; Reiffel JA; Singer DE; Peterson ED; Piccini JP
Heart; 2018 Nov; 104(22):1850-1858. PubMed ID: 29875139
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
18. Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding.
Mascarenhas DA; Farooq MU; Ziegler PD; Kantharia BK
Europace; 2016 Jun; 18(6):799-806. PubMed ID: 26614520
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Major Bleeding Among Working-Age Adults with Atrial Fibrillation: Evaluating the Effects of Potential Drug-drug Interactions and Switching from Warfarin to Non-vitamin K Oral Anticoagulants.
Feng X; Sambamoorthi U; Innes K; Castelli G; LeMasters T; Xiong L; Williams MU; Tan X
Cardiovasc Drugs Ther; 2018 Dec; 32(6):591-600. PubMed ID: 30315487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
